-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - standardized tool
to track symptoms (Mitchell, Trangle, Degnan, et al., 2013).
11
Meta-analyses
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-fullreport.pdf
January 01, 2019 - ., 1995) tested hydroxyurea in adults and adolescents (though the
latter were not separated out in analyses
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/patientsafety/2017qdr-patsafchartbook.pdf
October 01, 2018 - 36 | National Healthcare Quality and Disparities Report
Inability to protect deliberations or analyses … at a facility: The law permits providers to
undertake deliberations and analyses at their facilities
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/tobaccogenrefs.pdf
January 01, 2010 - A model for cost-effectiveness
analyses of smoking cessation interventions
applied to a quit-and-win … Pooled- and meta-
analyses of clinical trials of Bupropion SR.
Addiction 2004;99:1462-9.
498.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0087-fullreport.pdf
October 01, 2016 - Limited English Proficiency (LEP) Populations
Initial analyses of the manual EHR review data showed
-
www.monahrq.ahrq.gov/evidencenow/projects/heart-health/research-results/results/publications.html
June 01, 2023 - Final analyses on 12- and 18-month ABCS outcomes for the H3 study are forthcoming.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - Limited English Proficiency (LEP) Populations
Initial analyses of the manual review data showed that
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
January 01, 2020 - For our analyses, we used the more conservative
version of the PMCA, in which the identification of
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/asc/userguide/ascguide.pdf
April 01, 2015 - On
the basis of these analyses, as well as input from AHRQ and the TEP, the final survey items and
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
January 01, 2014 - Further, unadjusted and adjusted regression analyses indicated that parents of children at
moderate
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA0087-NCINQSexualActivityStatusForm.pdf
February 06, 2012 - Initial analyses of the manual EHR review data showed that at least 90% of adolescents within this sample
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
August 01, 2012 - Initial analyses of the manual review data showed that at least 90% of adolescents within this sample
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-fullreport.pdf
April 01, 2018 - In our adjusted analyses, we controlled for Chronic Condition Indicators (CCIs)
and length of hospitalization
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/hospital/userguide/hospitalusersguide.pdf
July 01, 2018 - Based on these analyses, the final items and composites in the
Hospital Survey on Patient Safety Culture
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-chsp-tin-linkage-file-tech-doc.pdf
January 01, 2018 - claim with a
positive allowed amount in 2018.xv We restrict the set of providers considered in the analyses
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cg/guidance-cg-cahps.pdf
April 01, 2021 - Psychometric analyses also indicate that
composite measures from the core items4 in the survey are reliable
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/overview/background/corebackgrnd.pdf
January 01, 2013 - /prevention, prognosis, diagnosis, differential diagnosis/symptom prevalence; economic and decision analyses